OMNY Health — a national data ecosystem that facilitates biotech and medical research — launched a data network consisting of EHR data from more than 645,000 GLP-1 users. The data network seeks to give OMNY’s life sciences and health system partners a vast source of GLP-1 data that is related to patient demographics and social…
GSK paid $85 million up front for global rights to a small-interfering RNA therapy discovered and developed by startup Empirico. The pharmaceutical giant said this drug candidate could be used as a monotherapy and as part of drug combinations for treating COPD and other inflammatory respiratory diseases. The post GSK’s Respiratory Pipeline Adds an Early-Stage…
Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, with algorithms soon able to manage routine tasks like blood pressure medication titration and diabetic retinopathy screening without human oversight. They argue automation is not just about efficiency, but also a practical and necessary…
Apellis Pharmaceuticals and Astellas Pharma have the first two FDA-approved therapies for geographic atrophy, but Character Biosciences claims its approach could be best in class for treating this advanced form of dry age-related macular degeneration. The biotech’s Series B round will finance clinical tests of two programs, each addressing a different stage of the disease….
SACRAMENTO, Calif. — In his earliest days in the governor’s office, Democrat Gavin Newsom huddled with his advisers to consider how to realize a key campaign promise: transforming a healthcare system replete with insurance company intermediaries into the nation’s first state-run single-payer model providing comprehensive coverage to all residents, similar to those in Canada and…
This blog post details ten things to know about the 2025 open enrollment period.
Screening for mental health symptoms in patients with significant allergic disease is not overreach The post How Diagnostic Precision in Allergy Care Supports Mental Well-Being appeared first on MedCity News.
Alzheon hoped testing its drug in a genetically defined subgroup of Alzheimer’s disease patients would succeed, overcoming earlier clinical trial failures. Instead, preliminary results show the pill failed to outdistance a placebo. The post Alzheon’s Precision Medicine Approach to Resurrect an Alzheimer’s Drug Fails Pivotal Study appeared first on MedCity News.
To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider organization plans. The post Rising Healthcare Costs: What Employers Are Doing to Manage Expenses, Per Mercer appeared first on MedCity News.
Jennifer Thompson, Medtronic’s vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters’ MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks. The post Medtronic Exec: AI Is Improving Device Launches & Patient Outcomes appeared first on…